secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2026-06-11T21:23:25+00:00
Accession:  0001493152-26-028322
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio appoints Jordan Zwick to board; shareholders approve 50% share increase to 450M
--------------------------------------------------------------------------------

- Jordan Zwick appointed to board, effective June 10, 2026; board expanded from five to six members.
- Zwick received initial RSU grant of $566,000, vesting in three equal annual installments.
- Stockholders approved amendment to increase authorized common shares from 300M to 450M, effective June 11, 2026.
- Stockholders approved Amended and Restated 2021 Equity Incentive Plan (42.257M shares) and Employee Stock Purchase Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer